• Ann Eakin, Senior Scientific Officer Office of Biodefense, Research Resources & Translational Research, DMID/NIAID/NIH
  • Dan Pevear, Sr. Vice President, Biology and Grants Development, VenatoRx Pharmaceuticals Incorporated

Moderator: François Franceschi, Project leader AMREP, GARDP

In this webinar, Ann Eakin (US National Institute of Allergy and Infectious Diseases, NIAID) provided an overview of the various mechanisms of support offered by NIAID to facilitate the discovery and development of drugs, vaccines and diagnostics targeting infectious diseases. The types of support that were discussed are grants and contracts, as well as preclinical and clinical research services that aim to reduce risk and advance product development efforts. Researchers from any country and from any type of institution (academia, industry, non-profit) are eligible to apply for nearly all types of support mechanisms offered by NIAID, irrespective of prior or current NIH funding.

Ann’s presentation was complemented by a short presentation by Dan Pevear (Senior Vice President, Biology and Grants Development, VenatoRx Pharmaceuticals), in which he shared VenatoRx’ experience with NIAID support mechanisms.

We hosted this live webinar including interactive Q&A session on 21 February 2019.

If you have questions or comments, please let us know: revive@gardp.org.